Is torsades de pointes a type of ventricular tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Torsades de Pointes a Type of Ventricular Tachycardia?

Yes, torsades de pointes is definitively classified as a specific type of polymorphic ventricular tachycardia that occurs in the setting of a prolonged QT interval. 1

Classification and Definition

Torsades de pointes is polymorphic ventricular tachycardia (VT) characterized by a waxing and waning QRS amplitude that occurs specifically when the QT interval is prolonged. 1 The 2017 AHA/ACC/HRS guidelines explicitly define it as "polymorphic VT that occurs in the setting of a long QT interval." 1

Key Distinguishing Features from Other VT Types

The classification of torsades as a VT subtype is based on several defining characteristics:

  • Rate criteria: It meets the fundamental VT definition of ≥3 consecutive ventricular complexes at a rate >100 bpm, specifically ranging from 160-240 bpm 1, 2
  • Morphology: Unlike monomorphic VT (stable single QRS morphology), torsades exhibits changing or multiform QRS morphology from beat to beat, which classifies it as polymorphic VT 1
  • Context-specific: The critical distinguishing feature is that it occurs exclusively in the setting of marked QT prolongation (>500 ms), which separates it from other polymorphic VTs 1

Why This Classification Matters Clinically

The classification as a specific VT subtype has critical therapeutic implications because torsades requires fundamentally different management than other ventricular tachycardias. 3, 4

Treatment Divergence from Standard VT

  • Contraindicated therapies: Standard class I antiarrhythmic agents used for other VTs will worsen torsades and are strictly contraindicated 3, 5
  • First-line treatment: IV magnesium sulfate 2g is the treatment of choice, regardless of serum magnesium level 2, 6, 3
  • Rate augmentation: Unlike other VTs where slowing the rate is beneficial, torsades requires heart rate acceleration through pacing or isoproterenol to shorten the QT interval 1, 3, 4

Relationship to Ventricular Fibrillation

While torsades is a type of VT, it has a unique relationship with ventricular fibrillation:

  • Self-termination: Unlike ventricular fibrillation, torsades frequently terminates spontaneously with the last 2-3 beats showing slowing 1, 7
  • Degeneration risk: However, it can degenerate into ventricular fibrillation and cause sudden cardiac death 1, 7
  • Distinct entity: The slower rate (160-240 bpm vs >300 bpm for VF) and visible QRS complexes distinguish it from ventricular fibrillation 7, 8

Clinical Recognition Pitfalls

The characteristic "twisting of the points" morphology may not always be visible, especially in nonsustained episodes or with limited ECG leads, but this does not change its classification as polymorphic VT. 1 The diagnosis should be based on the combination of polymorphic VT occurring with marked QT prolongation, not solely on visualizing the twisting pattern 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Torsades de Pointes: Clinical Overview and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug therapy for torsade de pointes.

Journal of cardiovascular electrophysiology, 1993

Research

A practical approach to torsade de pointes.

Clinical cardiology, 1997

Research

[Multiform ventricular tachycardias and Torsades de Pointe].

Giornale italiano di cardiologia, 1983

Research

Torsades de pointes: prevention and therapy.

Cardiovascular drugs and therapy, 1991

Guideline

Torsade de Pointes and Ventricular Fibrillation: Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Torsades de Pointes Characteristics and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.